TransUnion returns to the earnings stage on July 28 — days after an apparent scheduling shift from July 24 — with the bullish options tilt still intact but the stock trading lower than it was when the last preview was written.
The put/call ratio is running at 0.25, modestly below its 20-day average of 0.29 and roughly 1.2 standard deviations to the bullish side. That call-heavy skew has been a consistent feature since mid-July, when the ratio was tracking closer to 0.32. Options traders have not flinched. The stock, however, has: TRU pulled back about 4% on the week to $76.51, having given up some of the 16% monthly gain that remains on the books. Close peer EFX fell a similar 2.6% on the week, while SSNC bucked the sector, gaining more than 6% — suggesting the weakness in TRU is at least partly sector-driven rather than stock-specific.
Short interest has continued its steady climb. Bears added roughly 28% to their position over the past month, bringing short interest to 5.6% of the free float — about 10.9 million shares. That month-long build is the most notable change since the prior preview noted the same trend developing. Borrowing costs remain negligible at around 0.5%, and borrow availability is near 468%, meaning supply for new shorts is plentiful. The lending market is not generating squeeze pressure; the short position is a considered directional bet, not a technical overhang.
The bull-bear divide on TRU is well-established. Bulls point to TransUnion's diversified credit bureau franchise, its international footprint, and a track record of beating consensus estimates — EPS surprise ranks in the 92nd percentile of the ORTEX universe. The mean analyst price target near $90 implies roughly 17% upside from current levels. Bears are anchored on the debt load, AI disruption risk in credit reporting, and persistent macro headwinds in key international markets including India. The Street's overall posture is cautious: BofA and UBS both hold Neutral ratings, and Mizuho — which initiated coverage in April — also sits at Neutral. JPMorgan and Needham are the constructive outliers, carrying Overweight and Buy respectively. Recent analyst moves have been a mixed bag of modest target trims and one small raise, with no firm taking a strong directional step ahead of the print.
The July 28 report will test whether TRU can sustain the EPS beat streak that has defined its factor profile, and whether management's commentary on the macro and AI competitive backdrop is enough to give the bullish options positioning something concrete to work with.
See the live data behind this article on ORTEX.
Open TRU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
